Achim Temme

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Induced Apoptosis

Endoplasmic Reticulum Stress

Top Venues

International journal of molecular sciences

Angewandte Chemie (International ed. in English)

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Zhou, Kehu Zhang, Silvia Moreno, Achim Temme, Brigitte Voit, Dietmar Appelhans
Continuous Transformation from Membrane-Less Coacervates to Membranized Coacervates and Giant Vesicles: Toward Multicompartmental Protocells with Complex (Membrane) Architectures. Angewandte Chemie (International ed. in English) (2024)
Yang Zhou, Kehu Zhang, Silvia Moreno, Achim Temme, Brigitte Voit, Dietmar Appelhans
Continuous Transformation from Membrane-Less Coacervates to Membranized Coacervates and Giant Vesicles: Toward Multicompartmental Protocells with Complex (Membrane) Architectures. Angewandte Chemie (International ed. in English) 63 (34) (2024)
Dietmar Krex, Paula Bartmann, Doris Lachmann, Alexander Hagstotz, Willi Jugel, Rosa S Schneiderman, Karnit Gotlib, Yaara Porat, Katja Robel, Achim Temme, Moshe Giladi, Susanne Michen
Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas. International journal of molecular sciences 24 (5) (2023)
Dietmar Krex, Paula Bartmann, Doris Lachmann, Alexander Hagstotz, Willi Jugel, Rosa S Schneiderman, Karnit Gotlib, Yaara Porat, Katja Robel, Achim Temme, Moshe Giladi, Susanne Michen
Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas. International journal of molecular sciences 24 (5) (2023)
Dietmar Krex, Paula Bartmann, Doris Lachmann, Alexander Hagstotz, Willi Jugel, Rosa S Schneiderman, Karnit Gotlib, Yaara Porat, Katja Robel, Achim Temme, Moshe Giladi, Susanne Michen
Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas. International journal of molecular sciences 24 (5) (2023)
Shafiq Murad, Susanne Michen, Alexander Becker, Monika Füssel, Gabriele Schackert, Torsten Tonn, Frank Momburg, Achim Temme
NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme. International journal of molecular sciences 23 (10) (2022)
Willi Jugel, Stefanie Tietze, Jennifer Daeg, Dietmar Appelhans, Felix Broghammer, Achim Aigner, Michael Karimov, Gabriele Schackert, Achim Temme
Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers. Cancers 14 (8) (2022)
Maximilian Clausing, Doreen William, Matthias Preussler, Julia Biedermann, Konrad Grützmann, Susan Richter, Frank Buchholz, Achim Temme, Evelin Schröck, Barbara Klink
Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model. International journal of molecular sciences 23 (10) (2022)
Urban J Scheuring, Steffi Ritter, Daniel Martin, Gabriele Schackert, Achim Temme, Stefanie Tietze
GliPR1 knockdown by RNA interference exerts anti-glioma effects in vitro and in vivo. Journal of neuro-oncology 153 (1) (2021)
Isabell Schau, Susanne Michen, Alexander Hagstotz, Andreas Janke, Gabriele Schackert, Dietmar Appelhans, Achim Temme
Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis. Scientific reports 9 (1) (2019)
Lena Tienken, Natascha Drude, Isabell Schau, Oliver H Winz, Achim Temme, Elmar Weinhold, Felix M Mottaghy, Agnieszka Morgenroth
Evaluation of a Pretargeting Strategy for Molecular Imaging of the Prostate Stem Cell Antigen with a Single Chain Antibody. Scientific reports 8 (1) (2018)
Marina Conde, Susanne Michen, Ralf Wiedemuth, Barbara Klink, Evelin Schröck, Gabriele Schackert, Achim Temme
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells. BMC cancer 17 (1) (2017)